文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

干扰素调节因子3加重小鼠COVID-19严重程度

Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice.
PubMed 文献 · Crit Care Explor · 2025-03-17
一句话结论在K18-ACE2小鼠模型中,IRF3缺失可降低SARS-CoV-2感染后的死亡率(84.6% vs. 100%)并减轻疾病评分,而肺部病毒载量相似,提示IRF3在重症COVID-19中起有害作用。

研究使用表达人ACE2的K18-ACE2转基因小鼠,比较IRF3缺陷与IRF3充足小鼠感染SARS-CoV-2后的疾病表现。感染后小鼠出现剂量依赖性疾病,包括死亡、嗜睡、体重下降和肺部病理。IRF3缺陷小鼠免于严重疾病,死亡率降低(84.6% vs. 100%)且疾病评分降低。机制上,IRF3促进肺部IFN-β产生并重编程细胞因子谱,但肺部病毒载量在有无IRF3时相似。结论提示IRF3在小鼠COVID-19中起有害作用,与IFN-β和炎症细胞因子变化相关。

要点

  • 在K18-ACE2小鼠中,IRF3缺陷小鼠感染SARS-CoV-2后死亡率降低(84.6% vs. 100%)且疾病评分降低。
  • IRF3缺陷与IRF3充足小鼠的肺部病毒载量相似,提示IRF3未有效控制病毒载量。
  • IRF3促进肺部IFN-β产生并重编程细胞因子谱,可能与有害炎症相关。
  • 该研究为动物实验,结论不能直接转化为临床推荐。

适用人群与场景

  • K18-ACE2转基因小鼠(IRF3缺陷或IRF3充足),用于研究SARS-CoV-2感染后的疾病严重程度。

研究设计与关键结果

  • 研究类型:动物实验,使用K18-ACE2小鼠(IRF3缺陷或IRF3充足)感染SARS-CoV-2。
  • 感染后小鼠出现剂量依赖性疾病,表现为死亡、嗜睡、体重下降和肺部病理。
  • IRF3缺陷小鼠死亡率84.6% vs. IRF3充足小鼠100%,IRF3缺陷小鼠疾病评分降低。
  • 肺部病毒载量在有无IRF3时相似。
  • IRF3促进肺部IFN-β产生并重编程细胞因子谱。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠模型,不能直接改变急诊/ICU临床实践;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019, causing the COVID-19 pandemic. While most infected people experienced mild illness, others progressed to severe disease, characterized by hyperinflammation and respiratory distress. There is still much to learn about the innate immune response to this virus. Interferon regulatory factor 3 (IRF3) is a transcription factor that is activated when pattern recognition receptors detect viruses. Upon activation, IRF3 induces the expression of interferon beta (IFN-β) and interferon-stimulated genes, which protect the host from viral infection. However, coronaviruses antagonize this pathway, delaying type 1 IFN production. It is, therefore, unclear how IRF3 influences COVID-19 disease. Our prior reports showed that IRF3 promotes harmful inflammation during bacterial sepsis in mice.

HYPOTHESIS: We hypothesized that IRF3 cannot effectively control the SARS-CoV-2 viral load and instead promotes harmful inflammation during severe COVID-19.

METHODS AND MODELS: We used mice transgenic for the human angiotensin converting-enzyme 2 transgene, driven by the keratin 18 promoter (K18-ACE2 mice) that were IRF3 deficient or IRF3 sufficient to test how IRF3 influences COVID-19 disease.

RESULTS: Upon infection with SARS-CoV-2, K18-ACE2 mice showed a dose-dependent disease, characterized by mortality, lethargy, weight loss, and lung pathology, reminiscent of clinical COVID-19. However, K18-ACE2 mice lacking IRF3 were protected from severe disease with reduced mortality (84.6% vs. 100%) and disease score. We found that IRF3 promoted IFN-β production in the lungs and reprogrammed the cytokine profile, while viral load in the lungs was similar in the presence or absence of IRF3.

INTERPRETATIONS AND CONCLUSIONS: These data indicated that IRF3 played a detrimental role in murine COVID-19 associated with changes in IFN-β and inflammatory cytokines.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Walker WE, Garcia LF, Palermo PM, et al. Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice. Crit Care Explor. 2025. PMID: 40103621. doi:10.1097/CCE.0000000000001225

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。